Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes
- PMID: 23372684
- PMCID: PMC3553111
- DOI: 10.1371/journal.pone.0054191
Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes
Erratum in
- PLoS One. 2013;8(4). doi:10.1371/annotation/6032dd20-65b4-4d4d-bef6-7ba2ef6d3591
Abstract
Background: Proliferative vitreoretinopathy (PVR) is a destructive complication of retinal detachment and vitreoretinal surgery which can lead to severe vision reduction by tractional retinal detachments. The purpose of this study was to determine the gene expression profile of epiretinal membranes (ERMs) associated with a PVR (PVR-ERM) and to compare it to the expression profile of less-aggressive secondary ERMs.
Methodology/principal findings: A PCR-amplified complementary DNA (cDNA) library was constructed using the RNAs isolated from ERMs obtained during vitrectomy. The sequence from the 5' end was obtained for randomly selected clones and used to generate expressed sequence tags (ESTs). We obtained 1116 nonredundant clusters representing individual genes expressed in PVR-ERMs, and 799 clusters representing the genes expressed in secondary ERMs. The transcriptome of the PVR-ERMs was subdivided by functional subsets of genes related to metabolism, cell adhesion, cytoskeleton, signaling, and other functions, by FatiGo analysis. The genes highly expressed in PVR-ERMs were compared to those expressed in the secondary ERMs, and these were subdivided by cell adhesion, proliferation, and other functions. Querying 10 cell adhesion-related genes against the STRING database yielded 70 possible physical relationships to other genes/proteins, which included an additional 60 genes that were not detected in the PVR-ERM library. Of these, soluble CD44 and soluble vascular cellular adhesion molecule-1 were significantly increased in the vitreous of patients with PVR.
Conclusions/significance: Our results support an earlier hypothesis that a PVR-ERM, even from genomic points of view, is an aberrant form of wound healing response. Genes preferentially expressed in PVR-ERMs may play an important role in the progression of PVR and could be served as therapeutic targets.
Conflict of interest statement
Figures
Similar articles
-
Upregulation of RAGE and its ligands in proliferative retinal disease.Exp Eye Res. 2006 May;82(5):807-15. doi: 10.1016/j.exer.2005.09.022. Epub 2005 Dec 20. Exp Eye Res. 2006. PMID: 16364297
-
Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):3112-7. doi: 10.1167/iovs.15-17791. Invest Ophthalmol Vis Sci. 2016. PMID: 27294805 Free PMC article.
-
Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.Biomed Pharmacother. 2019 Mar;111:548-554. doi: 10.1016/j.biopha.2018.12.044. Epub 2018 Dec 28. Biomed Pharmacother. 2019. PMID: 30597308
-
Co-Expression of Podoplanin and CD44 in Proliferative Vitreoretinopathy Epiretinal Membranes.Int J Mol Sci. 2023 Jun 4;24(11):9728. doi: 10.3390/ijms24119728. Int J Mol Sci. 2023. PMID: 37298679 Free PMC article. Review.
-
[Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].Nippon Ganka Gakkai Zasshi. 2015 Nov;119(11):772-80. Nippon Ganka Gakkai Zasshi. 2015. PMID: 26685481 Review. Japanese.
Cited by
-
A Novel Role of IL13Rα2 in the Pathogenesis of Proliferative Vitreoretinopathy.Front Med (Lausanne). 2022 Jun 13;9:831436. doi: 10.3389/fmed.2022.831436. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35770008 Free PMC article.
-
FARNA: knowledgebase of inferred functions of non-coding RNA transcripts.Nucleic Acids Res. 2017 Mar 17;45(5):2838-2848. doi: 10.1093/nar/gkw973. Nucleic Acids Res. 2017. PMID: 27924038 Free PMC article.
-
Single-cell RNA sequencing in exploring the pathogenesis of diabetic retinopathy.Clin Transl Med. 2024 Jul;14(7):e1751. doi: 10.1002/ctm2.1751. Clin Transl Med. 2024. PMID: 38946005 Free PMC article. Review.
-
Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.PLoS One. 2020 Dec 21;15(12):e0243626. doi: 10.1371/journal.pone.0243626. eCollection 2020. PLoS One. 2020. PMID: 33347461 Free PMC article.
-
A Review of Last Decade Developments on Epiretinal Membrane Pathogenesis.Med Hypothesis Discov Innov Ophthalmol. 2020 Summer;9(2):91-110. Epub 2020 Mar 20. Med Hypothesis Discov Innov Ophthalmol. 2020. PMID: 32490016 Free PMC article. Review.
References
-
- Leiderman YI, Miller JW (2009) Proliferative vitreoretinopathy: pathobiology and therapeutic targets. Semin Ophthalmol 24: 62–69. - PubMed
-
- Wiedemann P, Hilgers RD, Bauer P, Heimann K (1998) Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 126: 550–559. - PubMed
-
- Kuo HK, Chen YH, Wu PC, Wu YC, Huang F, et al. (2012) Attenuated glial reaction in experimental proliferative vitreoretinopathy treated with liposomal Doxorubicin. Invest Ophthalmol Vis Sci 53: 3167–3174. - PubMed
-
- Wickham L, Bunce C, Wong D, McGurn D, Charteris DG (2007) Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology 114: 698–704. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous